Researchers at UC San Diego say they recently uncovered new insights into a protein that has emerged as a potential molecular “switch” that may determine whether Alzheimer’s-like brain changes lead to ...
The idea is straightforward: Take a blood test now, even without symptoms, and learn if you could some day develop ...
Sam Altman announces a $100M Alzheimer’s research fund, highlighting AI’s potential to enable faster diagnosis and treatment ...
Some brains resist Alzheimer's, even when the disease is already present. Researchers at the Netherlands Institute for ...
Should you receive a diagnosis of AD, many factors shape how symptoms unfold. The brain, even when under siege, retains an ...
A new study conducted by Indiana University School of Medicine researchers has found that primary care screenings for ...
Recognizing the signs of mild cognitive impairment meant Di could start treatment earlier to help slow her Alzheimer's ...
A common blood test marker may reveal Alzheimer’s risk years in advance. Elevated immune cells could signal danger early and ...
IV delivery of VY1706, a CNS penetrant AAV gene therapy for AD, demonstrates compelling pharmacology and safety in a 3-month ...
A widely publicised Cochrane review published on April 16, 2026, set out to synthesise evidence on the efficacy and safety of amyloid β-targeting monoclonal antibodies for Alzheimer's disease.1 The ...
The brain has its own immune system, which detects threats and mounts a defense. A growing body of evidence has shown that in ...
People have no control over Alzheimer's risk factors such as age, genes and family history. Diet, exercise and adequate sleep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results